550 related articles for article (PubMed ID: 9149887)
1. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
[TBL] [Abstract][Full Text] [Related]
2. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2007 Jan; 109(2):180-7. PubMed ID: 17154175
[TBL] [Abstract][Full Text] [Related]
3. [Atypical ductal and lobular hyperplasia of the breast].
Bricou A; Delpech Y; Barranger E
Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
[TBL] [Abstract][Full Text] [Related]
4. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
6. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
8. Radial scars in benign breast-biopsy specimens and the risk of breast cancer.
Jacobs TW; Byrne C; Colditz G; Connolly JL; Schnitt SJ
N Engl J Med; 1999 Feb; 340(6):430-6. PubMed ID: 9971867
[TBL] [Abstract][Full Text] [Related]
9. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.
Page DL; Dupont WD; Rogers LW
Cancer Detect Prev; 1986; 9(5-6):441-8. PubMed ID: 3779706
[TBL] [Abstract][Full Text] [Related]
12. Age-related lobular involution and risk of breast cancer.
Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
[TBL] [Abstract][Full Text] [Related]
13. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
[TBL] [Abstract][Full Text] [Related]
14. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
15. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
Mathes RW; Malone KE; Daling JR; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712
[TBL] [Abstract][Full Text] [Related]
16. Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia.
Whiffen A; El-Tamer M; Taback B; Feldman S; Joseph KA
Ann Surg Oncol; 2011 Feb; 18(2):463-7. PubMed ID: 20878246
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk factors in younger and older women.
Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
[TBL] [Abstract][Full Text] [Related]
19. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
[TBL] [Abstract][Full Text] [Related]
20. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy.
McLaren BK; Schuyler PA; Sanders ME; Jensen RA; Simpson JF; Dupont WD; Page DL
Cancer; 2006 Sep; 107(6):1227-33. PubMed ID: 16894523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]